Crescentis Capital re-appoints MD and CEO for five years

1 min read     Updated on 30 May 2026, 02:15 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Crescentis Capital Limited's board has approved the re-appointment of Mr. Subba Rao Veera Venkata Meka as Managing Director and Mr. Bhavanam Ruthvik Reddy as Whole-Time Director & CEO for a term of five years starting September 12, 2026. The re-appointments are subject to shareholder approval at the ensuing general meeting. The decisions follow recommendations by the Nomination and Remuneration Committee.

powered bylight_fuzz_icon
41633128

*this image is generated using AI for illustrative purposes only.

Crescentis Capital Limited has approved the re-appointment of its Managing Director and Whole-Time Director & CEO for a further term of five years starting September 12, 2026. The board's decision, taken on May 29, 2026, follows the recommendation of the Nomination and Remuneration Committee. These re-appointments are subject to the approval of shareholders at the ensuing general meeting and other statutory approvals.

Mr. Subba Rao Veera Venkata Meka has been re-appointed as Managing Director. His current term concludes at the close of business hours on September 11, 2026. Mr. Bhavanam Ruthvik Reddy has been re-appointed as Whole-Time Director & Chief Executive Officer, with his current term also ending on September 11, 2026. Both directors will serve for a period of five years from September 12, 2026.

The disclosure confirms there are no inter-se relationships between Mr. Subba Rao Veera Venkata Meka and other board members or senior management. However, Mr. Bhavanam Ruthvik Reddy is related to Mr. Bhaskara Rao Bollineni.

Director Profiles

Mr. Subba Rao Veera Venkata Meka brings over four decades of experience in domestic and international banking. He previously worked with Syndicate Bank, ABN AMRO, and The Royal Bank of Scotland (RBS). Since joining Crescentis Capital as Managing Director in September 2023, he has steered the company's transition from an investment-holding entity to an active Non-Banking Financial Company (NBFC).

Mr. Bhavanam Ruthvik Reddy holds a B.Tech in Civil Engineering and has over nine years of experience in business strategy and financial services. He has been associated with Krishna Institute of Medical Sciences (KIMS) since 2017. Serving as Whole-Time Director & CEO since September 12, 2023, he played a key role in commencing the company's NBFC operations in June 2025.

Re-appointment Details

Particulars Mr. Subba Rao Veera Venkata Meka Mr. Bhavanam Ruthvik Reddy
Designation Managing Director Whole-Time Director & CEO
Current Term End September 11, 2026 September 11, 2026
Re-appointment Date September 12, 2026 September 12, 2026
Term Five Years Five Years
Relationship None Related to Mr. Bhaskara Rao Bollineni

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-5.71%-10.23%-13.44%-8.58%+6.75%+641.31%

What strategic milestones does Crescentis Capital aim to achieve during the new five-year term to further solidify its NBFC operations?

How will the leadership team plan to expand the company's loan book and asset base following the recent transition to an active NBFC?

What potential impact will the relationship between Mr. Reddy and Mr. Bollineni have on corporate governance and strategic decision-making?

Crescentis Capital Limited Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 13 Apr 2026, 06:21 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Crescentis Capital Limited filed its quarterly SEBI compliance certificate for Q4FY26 on April 13, 2026, confirming adherence to Regulation 74(5) requirements. The certificate, provided by registrar RCMC Share Registry Private Limited, validates proper dematerialisation processes and regulatory compliance for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37630288

*this image is generated using AI for illustrative purposes only.

Crescentis capital Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The company filed the mandatory certificate with BSE Limited on April 13, 2026, demonstrating adherence to regulatory requirements for depositories and participants.

Regulatory Compliance Details

The certificate was filed in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This regulation mandates companies to submit quarterly confirmations regarding dematerialisation processes and related compliance matters.

Parameter: Details
Filing Date: April 13, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
Exchange: BSE Limited
Scrip Code: 511571

Registrar Confirmation

RCMC Share Registry Private Limited, serving as the company's Registrar and Share Transfer Agent, provided the compliance certificate dated April 1, 2026. The registrar confirmed that securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories.

Key confirmations from the registrar include:

  • Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
  • Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialisation were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners within 15 days

Company Information

Detail: Information
Current Name: Crescentis Capital Limited
Former Name: Som Datt Finance Corporation Limited
CIN: L65921TS1993PLC188494
Company Secretary: V V Krishna Chaitanya
Membership No: 49415
Location: Hyderabad

The filing was signed digitally by V V Krishna Chaitanya, Company Secretary and Compliance Officer, confirming the company's commitment to maintaining regulatory compliance and transparency in its operations.

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-5.71%-10.23%-13.44%-8.58%+6.75%+641.31%

What strategic initiatives might Crescentis Capital Limited pursue following its successful regulatory compliance demonstration?

How could potential changes to SEBI's depository regulations in 2026 impact the company's future compliance costs and processes?

Will the company's consistent regulatory compliance position it favorably for institutional investor interest or credit rating improvements?

More News on Crescentis Capital

1 Year Returns:+6.75%